{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:51:37Z","timestamp":1776214297257,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12308-025-00633-x","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T05:28:01Z","timestamp":1744694881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Day +\u2009100 bone marrow megakaryocyte count predicts transplant outcome in patients with high-risk myelodysplastic syndrome and acute leukemia"],"prefix":"10.1007","volume":"18","author":[{"given":"Zeynep Arzu","family":"Yegin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eeyma","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine Merve","family":"Sava\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"\u015eeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar","family":"Uyar G\u00f6\u00e7\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z\u00fcbeyde Nur","family":"\u00d6zkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalan","family":"Aky\u00fcrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fcnci","family":"Ya\u011fc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"633_CR1","doi-asserted-by":"publisher","first-page":"912060","DOI":"10.3389\/fonc.2022.912060","volume":"12","author":"H Zhan","year":"2022","unstructured":"Zhan H, Kaushansky K (2022) Megakaryocytes as the regulator of the hematopoietic vascular niche. Front Oncol 12:912060. https:\/\/doi.org\/10.3389\/fonc.2022.912060","journal-title":"Front Oncol"},{"key":"633_CR2","doi-asserted-by":"publisher","first-page":"906698","DOI":"10.3389\/fonc.2022.906698","volume":"12","author":"L Varricchio","year":"2022","unstructured":"Varricchio L, Hoffman R (2022) Megakaryocytes are regulators of the tumor microenvironment and malignant hematopoietic progenitor cells in myelofibrosis. Front Oncol 12:906698. https:\/\/doi.org\/10.3389\/fonc.2022.906698","journal-title":"Front Oncol"},{"key":"633_CR3","doi-asserted-by":"publisher","first-page":"840044","DOI":"10.3389\/fonc.2022.840044","volume":"12","author":"E Khatib-Massalha","year":"2022","unstructured":"Khatib-Massalha E, M\u00e9ndez-Ferrer S (2022) Megakaryocyte diversity in ontogeny, functions and cell-cell interactions. Front Oncol 12:840044. https:\/\/doi.org\/10.3389\/fonc.2022.840044","journal-title":"Front Oncol"},{"issue":"15","key":"633_CR4","doi-asserted-by":"publisher","first-page":"e2100921","DOI":"10.1002\/advs.202100921","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, Wu D, Xia M, Li M, Sun Z, Shen B, Liu Y, Jiang E, Wang H, Su P, Shi L, Xiao Z, Zhu X, Zhou W, Wang Q, Gao X, Cheng T, Zhou J (2021) Characterization of cellular heterogeneity and an immune subpopulation of human megakaryocytes. Adv Sci (Weinh) 8(15):e2100921. https:\/\/doi.org\/10.1002\/advs.202100921","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"633_CR5","doi-asserted-by":"publisher","first-page":"100053","DOI":"10.1016\/j.rpth.2023.100053","volume":"7","author":"AC Livada","year":"2023","unstructured":"Livada AC, Pariser DN, Morrell CN (2023) Megakaryocytes in the lung: history and future perspectives. Res Pract Thromb Haemost 7(2):100053. https:\/\/doi.org\/10.1016\/j.rpth.2023.100053","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"633_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCRESAHA.121.319821","volume":"130","author":"M Koupenova","year":"2022","unstructured":"Koupenova M, Livada AC, Morrell CN (2022) Platelet and megakaryocyte roles in innate and adaptive immunity. Circ Res 130(2):288\u2013308. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319821","journal-title":"Circ Res"},{"issue":"1","key":"633_CR7","doi-asserted-by":"publisher","first-page":"e137377","DOI":"10.1172\/JCI137377","volume":"131","author":"DN Pariser","year":"2021","unstructured":"Pariser DN, Hilt ZT, Ture SK, Blick-Nitko SK, Looney MR, Cleary SJ, Roman-Pagan E, Saunders J 2nd, Georas SN, Veazey J, Madere F, Santos LT, Arne A, Huynh NP, Livada AC, Guerrero-Martin SM, Lyons C, Metcalf-Pate KA, McGrath KE, Palis J, Morrell CN (2021) Lung megakaryocytes are immune modulatory cells. J Clin Invest 131(1):e137377. https:\/\/doi.org\/10.1172\/JCI137377","journal-title":"J Clin Invest"},{"issue":"6","key":"633_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/JLB.MR0718-261RR","volume":"105","author":"P Cunin","year":"2019","unstructured":"Cunin P, Nigrovic PA (2019) Megakaryocytes as immune cells. J Leukoc Biol 105(6):1111\u20131121. https:\/\/doi.org\/10.1002\/JLB.MR0718-261RR","journal-title":"J Leukoc Biol"},{"issue":"3","key":"633_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jbo.2016.02.007","volume":"5","author":"R Leblanc","year":"2016","unstructured":"Leblanc R, Peyruchaud O (2016) The role of platelets and megakaryocytes in bone metastasis. J Bone Oncol 5(3):109\u2013111. https:\/\/doi.org\/10.1016\/j.jbo.2016.02.007","journal-title":"J Bone Oncol"},{"issue":"1","key":"633_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1182\/blood-2016-01-636399","volume":"128","author":"R Leblanc","year":"2016","unstructured":"Leblanc R, Peyruchaud O (2016) Metastasis: new functional implications of platelets and megakaryocytes. Blood 128(1):24\u201331. https:\/\/doi.org\/10.1182\/blood-2016-01-636399","journal-title":"Blood"},{"key":"633_CR11","doi-asserted-by":"publisher","first-page":"1121401","DOI":"10.3389\/fonc.2023.1121401","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, Zhu C, Pan F, Chen Y, Xiong L, Li Y, Chu X, Huang G (2023) Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. Front Oncol 13:1121401. https:\/\/doi.org\/10.3389\/fonc.2023.1121401","journal-title":"Front Oncol"},{"issue":"23","key":"633_CR12","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1182\/blood.2019003978","volume":"137","author":"S D'Ambrosi","year":"2021","unstructured":"D\u2019Ambrosi S, Nilsson RJ, Wurdinger T (2021) Platelets and tumor-associated RNA transfer. Blood 137(23):3181\u20133191. https:\/\/doi.org\/10.1182\/blood.2019003978","journal-title":"Blood"},{"key":"633_CR13","doi-asserted-by":"publisher","first-page":"665534","DOI":"10.3389\/fonc.2021.665534","volume":"11","author":"A Braun","year":"2021","unstructured":"Braun A, Anders HJ, Gudermann T, Mammadova-Bach E (2021) Platelet-cancer interplay: molecular mechanisms and new therapeutic avenues. Front Oncol 11:665534. https:\/\/doi.org\/10.3389\/fonc.2021.665534","journal-title":"Front Oncol"},{"issue":"23","key":"633_CR14","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1182\/blood.2019003976","volume":"137","author":"HG Roweth","year":"2021","unstructured":"Roweth HG, Battinelli EM (2021) Lessons to learn from tumor-educated platelets. Blood 137(23):3174\u20133180. https:\/\/doi.org\/10.1182\/blood.2019003976","journal-title":"Blood"},{"issue":"23","key":"633_CR15","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1182\/blood.2019004119","volume":"137","author":"S Lazar","year":"2021","unstructured":"Lazar S, Goldfinger LE (2021) Platelets and extracellular vesicles and their cross talk with cancer. Blood 137(23):3192\u20133200. https:\/\/doi.org\/10.1182\/blood.2019004119","journal-title":"Blood"},{"issue":"5","key":"633_CR16","doi-asserted-by":"publisher","first-page":"188770","DOI":"10.1016\/j.bbcan.2022.188770","volume":"1877","author":"K Morris","year":"2022","unstructured":"Morris K, Schnoor B, Papa AL (2022) Platelet cancer cell interplay as a new therapeutic target. Biochim Biophys Acta Rev Cancer 1877(5):188770. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188770","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"633_CR17","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.clml.2019.01.001","volume":"19","author":"H Moneib","year":"2019","unstructured":"Moneib H, Hafez H, Abdalla A, Hassanain O, Lehmann L, Haddad AE (2019) Day +100 platelet count predicts survival after allogeneic hematopoietic stem-cell transplantation in children with hematologic malignancies. Clin Lymphoma Myeloma Leuk 19(5):e221\u2013e227. https:\/\/doi.org\/10.1016\/j.clml.2019.01.001","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"633_CR18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele G, R\u00f6llig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A, L\u00f6wenberg B (2017) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345\u20131377. https:\/\/doi.org\/10.1182\/blood.2022016867","journal-title":"Blood"},{"issue":"19","key":"633_CR19","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood.2023023568","volume":"143","author":"N G\u00f6kbuget","year":"2024","unstructured":"G\u00f6kbuget N, Boissel N, Chiaretti S, Dombret H, Doubek M, Fielding A, Fo\u00e0 R, Giebel S, Hoelzer D, Hunault M, Marks DI, Martinelli G, Ottmann O, Rijneveld A, Rousselot P, Ribera J, Bassan R (2024) Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143(19):1903\u20131930. https:\/\/doi.org\/10.1182\/blood.2023023568","journal-title":"Blood"},{"key":"633_CR20","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M (2009) Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 15:1628\u20131633. https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.004","journal-title":"Biol Blood Marrow Transplant"},{"key":"633_CR21","doi-asserted-by":"publisher","unstructured":"Averbuch D,\u00a0Orasch C,\u00a0Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH\/ESCMID and ELN (2013) European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 98:1826\u20131835. https:\/\/doi.org\/10.3324\/haematol.2013.091025","DOI":"10.3324\/haematol.2013.091025"},{"key":"633_CR22","doi-asserted-by":"publisher","unstructured":"Maertens JA, Girmenia C, Br\u00fcggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN) (2018) European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother 73:3221\u20133230. https:\/\/doi.org\/10.1093\/jac\/dky286","DOI":"10.1093\/jac\/dky286"},{"key":"633_CR23","doi-asserted-by":"publisher","unstructured":"Ljungman P,\u00a0de la Camara R,\u00a0Robin C, Crocchiolo R, Einsele H, Hill JA, Hubacek P, Navarro D, Cordonnier C, Ward KN; 2017 European Conference on Infections in Leukaemia group (2019) Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 19:e260-e272. https:\/\/doi.org\/10.1016\/S1473-3099(19)30107-0","DOI":"10.1016\/S1473-3099(19)30107-0"},{"key":"633_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 51:906\u2013912. https:\/\/doi.org\/10.1038\/bmt.2016.130","journal-title":"Bone Marrow Transplant"},{"key":"633_CR25","doi-asserted-by":"publisher","unstructured":"Cahn JY,\u00a0Klein JP,\u00a0Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Soci\u00e9 G; Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle et Th\u00e9rapie Cellulaire; Dana Farber Cancer Institute; International Bone Marrow Transplant Registry (2005) Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle et Th\u00e9rapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 106:1495-1500. https:\/\/doi.org\/10.1182\/blood-2004-11-4557","DOI":"10.1182\/blood-2004-11-4557"},{"key":"633_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME (2015) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21:389-401.e1. https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"633_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"MA Kharfan-Dabaja","year":"2021","unstructured":"Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA (2021) Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther 27(8):642\u2013649. https:\/\/doi.org\/10.1016\/j.jtct.2021.04.007","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"633_CR28","first-page":"29","volume":"8","author":"JA Ridgeway","year":"2017","unstructured":"Ridgeway JA, Tinsley S, Kurtin SE (2017) Practical guide to bone marrow sampling for suspected myelodysplastic syndromes. J Adv Pract Oncol 8(1):29\u201339","journal-title":"J Adv Pract Oncol"},{"key":"633_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1309\/AJCP67WITVPVVTNF","volume":"143","author":"W Lynch Douglas","year":"2015","unstructured":"Lynch Douglas W, Stauffer Stephanie L, Rosenthal Nancy S (2015) Adequacy of powered vs manual bone marrow biopsy specimens: a retrospective review of sequential marrow aspirates and biopsies in 68 patients. Am J of Clin Pathology 143:535\u2013539. https:\/\/doi.org\/10.1309\/AJCP67WITVPVVTNF","journal-title":"Am J of Clin Pathology"},{"issue":"5","key":"633_CR30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"W Vardiman James","year":"2009","unstructured":"Vardiman James W, J\u00fcergen T, Arber Daniel A, Brunning Richard D, Borowitz Michael J, Anna P, Lee HN, Le Beau MM, Eva H-L, Ayalew T, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937\u2013951. https:\/\/doi.org\/10.1182\/blood-2009-03-209262","journal-title":"Blood"},{"issue":"5","key":"633_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/ajcp\/aqw144","volume":"146","author":"MD Jawad","year":"2016","unstructured":"Jawad MD, Go RS, Reichard KK, Shi M (2016) Increased multinucleated megakaryocytes as an isolated finding in bone marrow: a rare finding and its clinical significance. Am J of Clin Pathology 146(5):561\u2013566. https:\/\/doi.org\/10.1093\/ajcp\/aqw144","journal-title":"Am J of Clin Pathology"},{"issue":"2","key":"633_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/ctr.12673","volume":"30","author":"H Fu","year":"2016","unstructured":"Fu H, Zhang X, Xu L, Liu K, Huang X (2016) Characterization of thrombopoietin kinetics within 60 days after allogeneic hematopoietic stem cell transplantation and its correlation with megakaryocyte ploidy distribution. Clin Transplant 30(2):170\u2013178. https:\/\/doi.org\/10.1111\/ctr.12673","journal-title":"Clin Transplant"},{"issue":"3","key":"633_CR33","doi-asserted-by":"publisher","first-page":"E233","DOI":"10.1111\/j.1399-0012.2011.01406.x","volume":"25","author":"A Rank","year":"2011","unstructured":"Rank A, Nieuwland R, Delker R, Pihusch V, Wilkowski R, Toth B, Kolb HJ, Pihusch R (2011) Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin Transplant 25(3):E233\u2013E242. https:\/\/doi.org\/10.1111\/j.1399-0012.2011.01406.x","journal-title":"Clin Transplant"},{"issue":"2","key":"633_CR34","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbmt.2010.09.007","volume":"17","author":"X Zhang","year":"2011","unstructured":"Zhang X, Fu H, Xu L, Liu D, Wang J, Liu K, Huang X (2011) Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes. Biol Blood Marrow Transplant 17(2):274\u2013280. https:\/\/doi.org\/10.1016\/j.bbmt.2010.09.007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"633_CR35","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1182\/bloodadvances.2022007849","volume":"7","author":"AE Au","year":"2023","unstructured":"Au AE, Corbin J, Lebois M, Gangatirkar P, Yassinson F, Hyslop SR, Cannon P, Mason KD, Li-Wai-Suen CSN, Garnham AL, Moujalled D, Cimmino L, Alexander WS, Josefsson EC (2023) Proinflammatory microenvironment promotes lymphoma progression in mice with high megakaryocyte and TPO levels. Blood Adv 7(8):1560\u20131571. https:\/\/doi.org\/10.1182\/bloodadvances.2022007849","journal-title":"Blood Adv"},{"issue":"2","key":"633_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/cells8020134","volume":"8","author":"P Maroni","year":"2019","unstructured":"Maroni P (2019) Megakaryocytes in bone metastasis: protection or progression? Cells 8(2):134. https:\/\/doi.org\/10.3390\/cells8020134","journal-title":"Cells"},{"issue":"17","key":"633_CR37","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1158\/1078-0432.CCR-16-3081","volume":"23","author":"L Xu","year":"2017","unstructured":"Xu L, Mao X, Guo T, Chan PY, Shaw G, Hines J, Stankiewicz E, Wang Y, Oliver RTD, Ahmad AS, Berney D, Shamash J, Lu YJ (2017) The novel association of circulating tumor cells and circulating megakaryocytes with prostate cancer prognosis. Clin Cancer Res 23(17):5112\u20135122. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3081","journal-title":"Clin Cancer Res"},{"issue":"8","key":"633_CR38","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1158\/0008-5472.CAN-16-1084","volume":"77","author":"W Jackson 3rd","year":"2017","unstructured":"Jackson W 3rd, Sosnoski DM, Ohanessian SE, Chandler P, Mobley A, Meisel KD, Mastro AM (2017) Role of megakaryocytes in breast cancer metastasis to bone. Cancer Res 77(8):1942\u20131954. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1084","journal-title":"Cancer Res"},{"issue":"2","key":"633_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1538-7836.2011.04571.x","volume":"10","author":"B Psaila","year":"2012","unstructured":"Psaila B, Lyden D, Roberts I (2012) Megakaryocytes, malignancy and bone marrow vascular niches. J Thromb Haemost 10(2):177\u2013188. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04571.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"633_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jbmr.204","volume":"26","author":"X Li","year":"2011","unstructured":"Li X, Koh AJ, Wang Z, Soki FN, Park SI, Pienta KJ, McCauley LK (2011) Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis. J Bone Miner Res 26(1):125\u2013134. https:\/\/doi.org\/10.1002\/jbmr.204","journal-title":"J Bone Miner Res"},{"issue":"3","key":"633_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/09537104.2020.1786043","volume":"32","author":"G Marcoux","year":"2021","unstructured":"Marcoux G, Laroche A, Espinoza Romero J, Boilard E (2021) Role of platelets and megakaryocytes in adaptive immunity. Platelets 32(3):340\u2013351. https:\/\/doi.org\/10.1080\/09537104.2020.1786043","journal-title":"Platelets"},{"issue":"11","key":"633_CR42","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1182\/blood-2009-12-259457","volume":"116","author":"O Winter","year":"2010","unstructured":"Winter O, Moser K, Mohr E, Zotos D, Kaminski H, Szyska M, Roth K, Wong DM, Dame C, Tarlinton DM, Schulze H, MacLennan IC, Manz RA (2010) Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood 116(11):1867\u20131875. https:\/\/doi.org\/10.1182\/blood-2009-12-259457","journal-title":"Blood"},{"issue":"3","key":"633_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cmet.2023.12.020","volume":"36","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Xu X, Zhang D, Zhao S, Wang C, Zhang G, Chen W, Liu J, Gong H, Rixiati Y, Li S, Shen T, Li J (2024) Targeting Erbin-mitochondria axis in platelets\/megakaryocytes promotes B cell-mediated antitumor immunity. Cell Metab 36(3):541-556.e9. https:\/\/doi.org\/10.1016\/j.cmet.2023.12.020","journal-title":"Cell Metab"},{"issue":"13","key":"633_CR44","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.3390\/cancers15133397","volume":"15","author":"C Gra\u0161i\u010d Kuhar","year":"2023","unstructured":"Gra\u0161i\u010d Kuhar C, Silvester J, Mencinger M, Ov\u010dari\u010dek T, \u010cema\u017ear M, Miceska S, Modic \u017d, Kuhar A, Jesenko T, Kloboves Prevodnik V (2023) Association of circulating tumor cells, megakaryocytes and a high immune-inflammatory environment in metastatic breast cancer. Cancers (Basel) 15(13):3397. https:\/\/doi.org\/10.3390\/cancers15133397","journal-title":"Cancers (Basel)"},{"issue":"21","key":"633_CR45","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-21-1180","volume":"81","author":"B Wu","year":"2021","unstructured":"Wu B, Ye Y, Xie S, Li Y, Sun X, Lv M, Yang L, Cui N, Chen Q, Jensen LD, Cui D, Huang G, Zuo J, Zhang S, Liu W, Yang Y (2021) Megakaryocytes mediate hyperglycemia-induced tumor metastasis. Cancer Res 81(21):5506\u20135522. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1180","journal-title":"Cancer Res"},{"key":"633_CR46","doi-asserted-by":"publisher","unstructured":"Roweth HG,\u00a0Malloy MW, Goreczny GJ, Becker IC, Guo Q, Mittendorf EA, Italiano JE Jr, McAllister SS, Battinelli EM (2022) Pro-inflammatory megakaryocyte gene expression in murine models of breast cancer. Sci Adv 8(41):eabo5224. https:\/\/doi.org\/10.1126\/sciadv.abo5224","DOI":"10.1126\/sciadv.abo5224"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00633-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00633-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00633-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:02:13Z","timestamp":1776211333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00633-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00633-x","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board. All procedures in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained from the study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"18"}}